You're right about the bid ask it was a little odd, but maybe just frantic buying going on
Yeah, there is a good chance for a quick buck if you time it right. Not a sure bet, though. Drug isn't even very effective, since 2 of 6 treated died. If something better comes along this stock could fall a lot, very fast. Also, hopefully the outbreak will not get that bad.
Zmapp is pre picked, been worked on by defense interests for years. So far 2 out of 6 died on the drug, so may be slightly better than a placebo. The sarepta drug was effective on monkeys, I agree with you would be nice to at least give it a try
100 years ago we quarantined every immigrant on Ellis island, now we don't even bother to check on the worst disease ever heard of in all human history. Simple measures still work, modern arrogance may get a lot of people sick for no good reason
Instead of electing a president, we elected Obama
Looked it up... statistically insignificant #'s but... a third of zmapp patients died, vs 50% untreated. That's only a handful of cases, though, with other factors possibly affecting results. Might be totally ineffective, definitely not a true cure.
thanks bud... just eyeballing charts has so far been my most successful strategy. more and more I find that dd is looking like a waste of time.
if they have bad news on optina next week, it shows that this pr was just a bs cover, which is a pattern for them. I know ampion is the main drug but doesn't matter. the blind study went in the garbage. subjective data is favorable. mri's are being evaluated... it's good news mainly because it's not bad news. not enough to save the stock